The Translational Research Group (TRG) within the TRO work in partnership with academics and clinicians across UCL and our partner hospitals to advance their science towards patient benefit.
As experienced project leaders, we establish credibility with our academics, to help you scope the projects' translational critical path, and assist with internal and external networking to link resources required, secure funding and provide research project management services.
The TRG works with academic and clinical researchers to produce competitive funding applications. Successfully securing this funding enables projects to de-risk and progress their therapeutic along the translational path towards the clinic.
Key activities include:
- TRO administration and provision of translational proof-of-concept funding for UCL researchers through the Therapeutic Acceleration Support (TAS) Fund.
- Identification of the most appropriate funding source for a project, whether internal or external to UCL, to target for support.
- Scoping and development of robust project plans to increase the chances of translational funding success.
The following case studies exemplify the funding support we provide.